A. Marilyn Leitch

2.5k total citations
44 papers, 1.6k citations indexed

About

A. Marilyn Leitch is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Marilyn Leitch has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 21 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in A. Marilyn Leitch's work include Breast Cancer Treatment Studies (24 papers), Breast Lesions and Carcinomas (9 papers) and Global Cancer Incidence and Screening (8 papers). A. Marilyn Leitch is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Breast Lesions and Carcinomas (9 papers) and Global Cancer Incidence and Screening (8 papers). A. Marilyn Leitch collaborates with scholars based in United States, India and Switzerland. A. Marilyn Leitch's co-authors include David Euhus, Kelly K. Hunt, Judy C. Boughey, Linda McCall, Elizabeth A. Mittendorf, Karla V. Ballman, Lee G. Wilke, Bret Taback, Teresa Flippo‐Morton and Gretchen Ahrendt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

A. Marilyn Leitch

43 papers receiving 1.6k citations

Peers

Countries citing papers authored by A. Marilyn Leitch

Since Specialization

Citations

This map shows the geographic impact of A. Marilyn Leitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Marilyn Leitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Marilyn Leitch more than expected).

Fields of papers citing papers by A. Marilyn Leitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Marilyn Leitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Marilyn Leitch. The network helps show where A. Marilyn Leitch may publish in the future.

Co-authorship network of co-authors of A. Marilyn Leitch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Marilyn Leitch. A scholar is included among the top collaborators of A. Marilyn Leitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Marilyn Leitch. A. Marilyn Leitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients 2023 ·Journal of Breast Cancer ·(unknown), Allen Yen, Asal Rahimi, (unknown), A. Marilyn Leitch, Ann Spangler, Prasanna Alluri, Chika Nwachukwu, (unknown), Deborah Farr, (unknown)	1
2	ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106. 2020 ·Journal of Clinical Oncology ·X. Cynthia, Vera J. Suman, A. Marilyn Leitch, Souzan Sanati, Kiran Vij, Gary Unzeitig, Jeremy Hoog, Mark A. Watson, Olwen Hahn, J. Michael Guenther, Abigail S. Caudle, Travis Dockter, Larissa A. Korde, Anna Weiss, Kelly K. Hunt, Clifford A. Hudis, Eric P. Winer, Ann H. Partridge, Lisa A. Carey, Matthew J. Ellis, (unknown)	27
3	Differences in Re-excision Rates for Breast-Conserving Surgery Using Intraoperative 2D Versus 3D Tomosynthesis Specimen Radiograph 2020 ·Annals of Surgical Oncology ·(unknown), (unknown), Ali H. Mokdad, (unknown), (unknown), Edward Clifford, Deborah Farr, (unknown), (unknown), A. Marilyn Leitch	12
4	Mammographic density changes in surgical weight loss-an indication for personalized screening 2018 ·BMC Medical Imaging ·(unknown), Ali H. Mokdad, Nancy Puzziferri, (unknown), Stephen Seiler, Alana Christie, Deborah Farr, Aeisha Rivers, A. Marilyn Leitch, (unknown), James F. Huth, Roshni Rao	7
5	Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay: A 10-Year Experience and Impact of Test Standardization on Concordance Rate 2015 ·Archives of Pathology & Laboratory Medicine ·Venetia Sarode, (unknown), Alana Christie, Rebecca Collins, Roshni Rao, A. Marilyn Leitch, David Euhus, Barbara Haley	20
6	Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer 2014 ·Annals of Surgery ·Judy C. Boughey, Linda McCall, Karla V. Ballman, Elizabeth A. Mittendorf, Gretchen Ahrendt, Lee G. Wilke, Bret Taback, A. Marilyn Leitch, Teresa Flippo‐Morton, Kelly K. Hunt	322
7	Analysis of Internet Usage Among Cancer Patients in a County Hospital Setting: A Quality Improvement Initiative 2014 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), (unknown), Xian-Jin Xie, (unknown), (unknown), (unknown), A. Marilyn Leitch, Roshni Rao	6
8	Factors Affecting Sentinel Lymph Node Identification Rate After Neoadjuvant Chemotherapy for Breast Cancer Patients Enrolled in ACOSOG Z1071 (Alliance) 2014 ·Annals of Surgery ·Judy C. Boughey, Vera J. Suman, Elizabeth A. Mittendorf, Gretchen Ahrendt, Lee G. Wilke, Bret Taback, A. Marilyn Leitch, Teresa Flippo‐Morton, Henry M. Kuerer, Monet W. Bowling, Kelly K. Hunt	110
9	ACOSOG Z1041 (Alliance): Definitive analysis of randomized neoadjuvant trial comparing FEC followed by paclitaxel plus trastuzumab (FEC → P+T) with paclitaxel plus trastuzumab followed by FEC plus trastuzumab (P+T → FEC+T) in HER2+ operable breast cancer. 2013 ·Journal of Clinical Oncology ·Aman U. Buzdar, Vera J. Suman, Funda Meric‐Bernstam, A. Marilyn Leitch, Matthew J. Ellis, Judy C. Boughey, Gary Unzeitig, Melanie Royce, Kelly K. Hunt	10
10	Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection 2012 ·Annals of Surgery ·Kelly K. Hunt, Karla V. Ballman, Linda McCall, Judy C. Boughey, Elizabeth A. Mittendorf, Charles E. Cox, Pat W. Whitworth, Peter D. Beitsch, A. Marilyn Leitch, Thomas A. Buchholz, Monica Morrow, Armando E. Giuliano	71
11	Role of axillary ultrasound after neoadjuvant chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis (ACOSOG Z1071). 2012 ·Journal of Clinical Oncology ·Huong T. Le‐Petross, Linda McCall, Kelly K. Hunt, Elizabeth A. Mittendorf, Gretchen Ahrendt, Lee G. Wilke, A. Marilyn Leitch, Bret Taback, Judy C. Boughey	2
12	Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non‐palpable breast lesions 2011 ·Journal of Surgical Oncology ·(unknown), (unknown), David Euhus, Roshni Rao, Ralph Wynn, (unknown), A. Marilyn Leitch	49
13	Aesthetic Subunit of the Breast 2011 ·Annals of Plastic Surgery ·Steven H. Bailey, Michel Saint‐Cyr, Georgette Oni, Munique Maia, (unknown), Arash Shirvani, Viet Nguyen, Corrine Wong, Song Zhang, A. Marilyn Leitch, David Euhus, Roshni Rao, Rod J. Rohrich	12
14	Controversies in Breast Surgery 2010 ·Annals of Surgical Oncology ·Judy C. Boughey, Elizabeth A. Mittendorf, Lawrence J. Solin, J. Michael Dixon, Todd M. Tuttle, Peter D. Beitsch, Hiram S. Cody, A. Marilyn Leitch, Lisa A. Newman	9
15	Delays in Time to Treatment and Survival Impact in Breast Cancer 2010 ·Annals of Surgical Oncology ·(unknown), Jordan M. Estroff, David Euhus, A. Marilyn Leitch, James F. Huth, Valerie Andrews, Amy Moldrem, Roshni Rao	89
16	Patient variables that predict atypical cytology by nipple duct lavage 2007 ·Cancer ·(unknown), Raheela Ashfaq, A. Marilyn Leitch, David Euhus	6
17	Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer 2005 ·The American Journal of Surgery ·A. Marilyn Leitch, Peter D. Beitsch, Linda McCall, Katherine E. Posther, Lisa A. Newman, James E. Herndon, Kelly K. Hunt, Armando E. Giuliano	23
18	Promoter Hypermethylation in Benign Breast Epithelium in Relation to Predicted Breast Cancer Risk 2005 ·Clinical Cancer Research ·Cheryl Lewis, Leslie Cler, (unknown), Sabine Zöchbauer‐Müller, Sara Milchgrub, Elizabeth Z. Naftalis, A. Marilyn Leitch, John D. Minna, David Euhus	143
19	Patient and duct selection for nipple duct lavage 2004 ·The American Journal of Surgery ·(unknown), Raheela Ashfaq, Elizabeth Z. Naftalis, A. Marilyn Leitch, Susan Hoover, David Euhus	14
20	Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic 2002 ·The Breast Journal ·David Euhus, A. Marilyn Leitch, James F. Huth, George N. Peters	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact